Skip to content
Inciteful Med

Navigating High-Risk Situations: Surgery, Pregnancy, and Hormones

Last updated:

During surgery and pregnancy, patients with congenital antithrombin deficiency face high blood clot risks. Safe management requires antithrombin concentrate (ATc) infusions and specialized low molecular weight heparin (LMWH) monitoring using an antithrombin-supplemented anti-Xa test.

Key Takeaways

  • • Major surgery requires antithrombin concentrate (ATc) infusions to temporarily normalize antithrombin levels and prevent dangerous blood clots.
  • • Standard heparin lab tests are inaccurate for patients with antithrombin deficiency and require a specialized antithrombin-supplemented anti-Xa assay.
  • • The six-week postpartum period immediately following childbirth is the highest-risk time for developing a blood clot.
  • • Starting blood thinners early in pregnancy can help prevent placenta-related complications like preeclampsia and restricted fetal growth.

While having Congenital Antithrombin Deficiency means you live with a higher baseline risk for blood clots, certain life events create “high-risk windows” that require specialized medical attention. Surgery and pregnancy are the two most significant challenges for patients with this condition [1][2]. However, with advanced planning and the use of Antithrombin Concentrate (ATc), these events can be managed safely and successfully [3][4].

Navigating Surgery

Major surgery naturally increases the body’s tendency to clot. For someone with antithrombin deficiency, standard blood thinners (like heparin) may not be enough because they rely on the very protein you are missing [1].

  • The Protocol: To ensure safety, doctors often use a “bridging” strategy. This involves infusing Antithrombin Concentrate (ATc) to temporarily normalize your levels [5][6].
  • Target Levels: In major procedures, specialists often aim for an antithrombin activity level of 120% or higher before surgery and maintaining it at 80% or higher afterward [4].
  • Safe Anesthesia: Normalizing your antithrombin levels with ATc makes it safer for you to receive regional anesthesia, such as an epidural or spinal block, by reducing the risk of bleeding or clotting around the spine [7][5].

Managing Pregnancy and Postpartum

Pregnancy is a “hypercoagulable” state, meaning every person’s blood clots more easily to prevent excessive bleeding during birth. For women with antithrombin deficiency, this risk is amplified, with a lifetime VTE risk estimated between 50% and 90% [1].

  • LMWH Monitoring and the Heparin Trap: You might wonder why Low Molecular Weight Heparin (LMWH) is used daily if antithrombin deficiency causes “heparin resistance.” While standard doses might not work well, specialists can safely use LMWH during pregnancy by carefully adjusting the dose to your specific needs, and sometimes combining it with antithrombin concentrate [8][9].
  • Crucial Safety Warning on Anti-Xa Tests: To ensure your LMWH dose is correct, your doctor will monitor anti-Xa levels in your blood [8][10]. However, standard anti-Xa tests rely on your own antithrombin to work, which will falsely show low heparin levels in your blood. This can trick doctors into dangerously increasing your heparin dose. You must ensure your lab uses a specialized “antithrombin-supplemented” anti-Xa assay.
  • Labor and Delivery: Around the time of delivery, anticoagulation is often paused briefly. During this window, Antithrombin Concentrate (ATc) is frequently used to provide protection while the blood thinners are out of your system [3][11].
  • The Postpartum Surge: The six weeks after giving birth are actually the highest-risk period for a blood clot [2][1]. You will likely need to continue therapeutic-dose anticoagulation throughout this entire period [12].

Protecting the Pregnancy

Beyond the risk of blood clots in the mother, antithrombin deficiency is linked to “placenta-mediated” complications [9][13]:

  • Preeclampsia: A condition involving dangerously high blood pressure during pregnancy [14][15].
  • IUGR (Intrauterine Growth Restriction): Where the baby does not grow at the expected rate [14].
  • Management: Starting LMWH early—often before the 16th week of pregnancy—has been shown to reduce the risk of these complications [14][13].

With a team that includes a hematologist and, for pregnancy, a Maternal-Fetal Medicine (MFM) specialist, these high-risk periods can be navigated with confidence [8][16].

Frequently Asked Questions

How is congenital antithrombin deficiency managed during major surgery?
Doctors often use a bridging strategy by infusing antithrombin concentrate (ATc) before and after surgery. This normalizes your levels, reduces the risk of clotting, and makes it safer to receive regional anesthesia.
Why do I need a special lab test for heparin during pregnancy?
Standard anti-Xa blood tests rely on your body's antithrombin to measure heparin levels. Because your natural levels are low, these tests will falsely show low heparin levels, which can trick doctors into prescribing dangerously high medication doses. You must ask your lab for an antithrombin-supplemented anti-Xa test.
When is the highest risk of blood clots during pregnancy with this condition?
The highest-risk period for developing a blood clot is actually the six weeks immediately following childbirth, known as the postpartum period. You will likely need to stay on full-dose anticoagulants during this entire time.
Can antithrombin deficiency affect the baby during pregnancy?
Yes, this condition increases the risk of placenta-related complications, such as preeclampsia and restricted fetal growth (IUGR). Starting blood thinners like low molecular weight heparin early in pregnancy can help reduce these risks.

Questions for Your Doctor

  • • What are the target antithrombin activity levels you want to see before and after my surgery?
  • • Will I receive antithrombin concentrate (ATc) during my hospital stay, and how often will it be infused?
  • • For pregnancy: How often will you check my anti-Xa levels using an antithrombin-supplemented test?
  • • What is the specific plan for my delivery to ensure I can safely receive an epidural or spinal anesthesia?
  • • How long will I need to stay on 'full-dose' anticoagulation after I give birth?

Questions for You

  • • Do I have a copy of my 'perioperative plan' to share with any surgeon or anesthesiologist I see?
  • • If I am planning a pregnancy, have I met with a Maternal-Fetal Medicine (MFM) specialist who is familiar with antithrombin deficiency?
  • • Am I prepared for the 6-week postpartum period, which is the highest-risk time for a blood clot?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Management of Venous Thromboembolism in Patients with Hereditary Antithrombin Deficiency and Pregnancy: Case Report and Review of the Literature.

    Refaei M, Xing L, Lim W, et al.

    Case reports in hematology 2017; (2017()):9261351 doi:10.1155/2017/9261351.

    PMID: 28168066
  2. 2

    Venous thromboembolism in pregnancy: recent advances.

    Kozak M, Cosmi B, Gerotziafas G, et al.

    Polish archives of internal medicine 2025; (135(7-8)) doi:10.20452/pamw.17081.

    PMID: 40792350
  3. 3

    Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol.

    Morikawa M, Ieko M, Nakagawa-Akabane K, et al.

    International journal of hematology 2022; (116(1)):60-70 doi:10.1007/s12185-022-03327-7.

    PMID: 35316497
  4. 4

    Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency.

    Nishimura Y, Takagi Y

    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2018; (24(4)):187-192 doi:10.5761/atcs.oa.18-00030.

    PMID: 29681597
  5. 5

    Perioperative Management of Hereditary Antithrombin Deficiency in a Patient Undergoing Minimally Invasive Thoracic Surgery: A Case Report.

    Domen H, Takakuwa Y, Yamada H

    Surgical case reports 2025; (11(1)) doi:10.70352/scrj.cr.25-0166.

    PMID: 41437950
  6. 6

    Hereditary antithrombin deficiency pilot project registry from the American Thrombosis and Hemostasis Network.

    DeSancho MT, Suvar E, Roberts JC, et al.

    Journal of thrombosis and haemostasis : JTH 2024; (22(11)):3183-3190 doi:10.1016/j.jtha.2024.07.026.

    PMID: 39151704
  7. 7

    Prolonged Neural Block After Lower-Limb Nerve Blocks in a Patient with Inherited Antithrombin III Deficiency: Implications for Regional Anesthesia.

    Aizawa T, Sugiura N, Sugita S

    Local and regional anesthesia 2025; (18()):151-156 doi:10.2147/LRA.S563087.

    PMID: 41480052
  8. 8

    Severe antithrombin deficiency in pregnancy: Achieving adequate anticoagulation.

    Pearson-Stuttard B, Bagot C, Ciantar E, et al.

    Obstetric medicine 2019; (12(1)):45-51 doi:10.1177/1753495X17741025.

    PMID: 30891093
  9. 9

    Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study.

    Abbattista M, Gianniello F, Novembrino C, et al.

    The Lancet. Haematology 2020; (7(4)):e320-e328 doi:10.1016/S2352-3026(20)30007-7.

    PMID: 32112716
  10. 10

    Anticoagulant management in an antithrombin-deficient pregnant woman with a history of venous thromboembolism: a case report.

    Kozak M, Vižintin Cuderman T, Božič Mijovski M, et al.

    Thrombosis journal 2025; (23(1)):94 doi:10.1186/s12959-025-00775-z.

    PMID: 41063127
  11. 11

    Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: a single-center experience.

    Bruzzese A, Santoro C, Baldacci E, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2019; (30(6)):304-307 doi:10.1097/MBC.0000000000000835.

    PMID: 31419212
  12. 12

    Issues in the Diagnosis and Management of Hereditary Antithrombin Deficiency.

    Bauer KA, Nguyen-Cao TM, Spears JB

    The Annals of pharmacotherapy 2016; (50(9)):758-67 doi:10.1177/1060028016651276.

    PMID: 27281301
  13. 13

    Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis.

    Akinshina S, Makatsariya A, Bitsadze V, et al.

    Journal of perinatal medicine 2018; (46(8)):893-899 doi:10.1515/jpm-2017-0329.

    PMID: 29949514
  14. 14

    Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.

    Cruz-Lemini M, Vázquez JC, Ullmo J, Llurba E

    American journal of obstetrics and gynecology 2022; (226(2S)):S1126-S1144.e17 doi:10.1016/j.ajog.2020.11.006.

    PMID: 34301348
  15. 15

    Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.

    Chen J, Huai J, Yang H

    BMC pregnancy and childbirth 2024; (24(1)):68 doi:10.1186/s12884-023-06218-9.

    PMID: 38233773
  16. 16

    Anti-Xa directed low-molecular-weight heparin dosing to reduce the risk of venous thromboembolism in pregnant women with inherited antithrombin deficiency.

    Dix C, Breen K, Robinson S, et al.

    Journal of thrombosis and haemostasis : JTH 2026; (24(1)):234-240 doi:10.1016/j.jtha.2025.07.031.

    PMID: 40784553

This page is for informational purposes only and does not replace professional medical advice. Always consult your hematologist and care team before undergoing surgery or planning a pregnancy.

Stay up to date

Get notified when new research about Hereditary thrombophilia due to congenital antithrombin deficiency is published.

No spam. Unsubscribe anytime.